Mahamaya Lifesciences is launching a book-built IPO to raise ₹70.44 crore.
Of this, ₹64.28 crore will come from new shares, while existing shareholders will sell shares worth ₹6.16 crore.
This SME IPO opens on November 11, 2025, and closes on November 13, 2025.
The allotment process will be completed by November 14, and the shares are expected to list on the BSE SME platform on November 18, 2025.
The IPO price band is set at ₹108 to ₹114 per share, with one lot containing 1,200 shares.
Retail investors must buy at least 2 lots (2,400 shares), requiring an investment of approximately ₹2.74 lakh.
High-net-worth investors (HNIs) must buy at least 3 lots, requiring about ₹4.10 lakh.
About Mahamaya Lifesciences
Founded in 2002, Mahamaya Lifesciences manufactures, registers, and exports agricultural and soil health products.
The company focuses on helping farmers improve productivity with high-quality pesticides and bio-products.
Mahamaya specializes in pesticide formulations, supplying major agrochemical companies and multinational corporations in India.
It imports molecules researched globally, registers them with the Central Insecticides Board, and provides them to Indian manufacturers and foreign companies.
The company has also registered products internationally, with markets in the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey.
It provides both data support and high-quality products to help its partners meet international registration requirements.
Financial Performance
Mahamaya Lifesciences has shown strong growth:
FY25 Revenue: ₹267.17 crore (up 64%)
FY25 Profit after Tax: ₹12.94 crore (up 148%)
Current Fiscal (ending June 30, 2025): Revenue ₹84.04 crore, Profit ₹4.10 crore
Use of IPO Proceeds
The company plans to use the IPO funds for expansion and development:
₹3.75 crore for new equipment at its existing formulation plant
₹29.42 crore to set up a new technical manufacturing plant
₹2.53 crore for a new warehouse and machinery
₹18 crore for working capital
Remaining funds for general corporate purposes
This funding will help Mahamaya increase production capacity, enhance operations, and support growth plans.
Important Players in the IPO
Book Running Lead Manager: OneView Corporate Advisors Pvt Ltd
Registrar: KFin Technologies Ltd
Market Maker: Mansi Share & Stock Broking Pvt Ltd
